Literature DB >> 18424511

A folded and functional protein domain in an amyloid-like fibril.

Mirko Sackewitz1, Sabrina von Einem, Gerd Hause, Michael Wunderlich, Franz-Xaver Schmid, Elisabeth Schwarz.   

Abstract

The effect of the polypeptide environment on polyalanine-induced fibril formation was investigated with amyloidogenic fragments from PAPBN1, a nuclear protein controlling polyadenylation. Mutation-caused extensions of the natural 10 alanine sequence up to maximally 17 alanines result in fibril formation of PABPN1 and the development of the disease oculopharyngeal muscular dystrophy (OPMD). We explored the influence of fibril formation on the structure and function of a one-domain protein linked to the fibril-forming part of PABPN1. The well-characterized, stably folded, one-domain protein, cold-shock protein CspB from Bacillus subtilis, was fused either to the C terminus of the entire N-terminal domain of PABPN1 or directly to peptides consisting of 10 or 17 alanine residues. The fusion protein between the N-terminal domain of PABPN1 and CspB formed fibrils in which the structure and activity of CspB were retained. In the fibrils formed by fusions in which the polyalanine sequence was directly linked to CspB, CspB was unfolded. These results indicate that the folded conformation and the function of a protein domain can be maintained in amyloid-like fibrils, and that the distance between this domain and the fibril plays an important role.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424511      PMCID: PMC2386740          DOI: 10.1110/ps.073276308

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  58 in total

1.  Congo red, doxycycline, and HSP70 overexpression reduce aggregate formation and cell death in cell models of oculopharyngeal muscular dystrophy.

Authors:  Y P Bao; S Sarkar; E Uyama; D C Rubinsztein
Journal:  J Med Genet       Date:  2004-01       Impact factor: 6.318

2.  Conformational variations in an infectious protein determine prion strain differences.

Authors:  Motomasa Tanaka; Peter Chien; Nariman Naber; Roger Cooke; Jonathan S Weissman
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

Review 3.  Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies.

Authors:  Aida Abu-Baker; Guy A Rouleau
Journal:  Biochim Biophys Acta       Date:  2006-10-11

4.  Effect of oculopharyngeal muscular dystrophy-associated extension of seven alanines on the fibrillation properties of the N-terminal domain of PABPN1.

Authors:  Grit Lodderstedt; Simone Hess; Gerd Hause; Till Scheuermann; Thomas Scheibel; Elisabeth Schwarz
Journal:  FEBS J       Date:  2007-01       Impact factor: 5.542

Review 5.  Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.

Authors:  M Borrell-Pagès; D Zala; S Humbert; F Saudou
Journal:  Cell Mol Life Sci       Date:  2006-11       Impact factor: 9.261

6.  T-rich DNA single strands bind to a preformed site on the bacterial cold shock protein Bs-CspB.

Authors:  Klaas E A Max; Markus Zeeb; Ralf Bienert; Jochen Balbach; Udo Heinemann
Journal:  J Mol Biol       Date:  2006-06-02       Impact factor: 5.469

7.  Biochemical and functional analysis of the assembly of full-length Sup35p and its prion-forming domain.

Authors:  Joanna Krzewska; Motomasa Tanaka; Steven G Burston; Ronald Melki
Journal:  J Biol Chem       Date:  2006-11-22       Impact factor: 5.157

Review 8.  Folding proteins in fatal ways.

Authors:  Dennis J Selkoe
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

9.  Hofmeister salts and potential therapeutic compounds accelerate in vitro fibril formation of the N-terminal domain of PABPN1 containing a disease-causing alanine extension.

Authors:  Grit Lodderstedt; Rolf Sachs; Jürgen Faust; Frank Bordusa; Uwe Kühn; Ralph Golbik; Andreas Kerth; Elmar Wahle; Jochen Balbach; Elisabeth Schwarz
Journal:  Biochemistry       Date:  2008-01-19       Impact factor: 3.162

10.  Trinucleotide expansions leading to an extended poly-L-alanine segment in the poly (A) binding protein PABPN1 cause fibril formation.

Authors:  Till Scheuermann; Barbe Schulz; Alfred Blume; Elmar Wahle; Rainer Rudolph; Elisabeth Schwarz
Journal:  Protein Sci       Date:  2003-12       Impact factor: 6.725

View more
  6 in total

1.  Protein chemistry: catalytic amyloid fibrils.

Authors:  Tobias Aumüller; Marcus Fändrich
Journal:  Nat Chem       Date:  2014-04       Impact factor: 24.427

Review 2.  Oculopharyngeal muscular dystrophy: a polyalanine myopathy.

Authors:  Bernard Brais
Journal:  Curr Neurol Neurosci Rep       Date:  2009-01       Impact factor: 5.081

3.  Polyalanine-independent conformational conversion of nuclear poly(A)-binding protein 1 (PABPN1).

Authors:  Reno Winter; Uwe Kühn; Gerd Hause; Elisabeth Schwarz
Journal:  J Biol Chem       Date:  2012-05-08       Impact factor: 5.157

4.  Influence of the stability of a fused protein and its distance to the amyloidogenic segment on fibril formation.

Authors:  Anja Buttstedt; Reno Winter; Mirko Sackewitz; Gerd Hause; Franz-Xaver Schmid; Elisabeth Schwarz
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

5.  Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy.

Authors:  Nicolas Barbezier; Aymeric Chartier; Yannick Bidet; Anja Buttstedt; Cécile Voisset; Hervé Galons; Marc Blondel; Elisabeth Schwarz; Martine Simonelig
Journal:  EMBO Mol Med       Date:  2011-01       Impact factor: 12.137

6.  The C-terminus hot spot region helps in the fibril formation of bacteriophage-associated hyaluronate lyase (HylP2).

Authors:  Harish Shukla; Sudhir Kumar Singh; Amit Kumar Singh; Kalyan Mitra; Md Sohail Akhtar
Journal:  Sci Rep       Date:  2015-09-23       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.